JPS6014024B2 - Method for producing optically active N-halosulfilimines - Google Patents
Method for producing optically active N-halosulfiliminesInfo
- Publication number
- JPS6014024B2 JPS6014024B2 JP8431676A JP8431676A JPS6014024B2 JP S6014024 B2 JPS6014024 B2 JP S6014024B2 JP 8431676 A JP8431676 A JP 8431676A JP 8431676 A JP8431676 A JP 8431676A JP S6014024 B2 JPS6014024 B2 JP S6014024B2
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- group
- formula
- reaction
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 230000003287 optical effect Effects 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 12
- -1 rt-butyl group Chemical group 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000002140 halogenating effect Effects 0.000 description 5
- 230000006340 racemization Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000011914 asymmetric synthesis Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 150000001923 cyclic compounds Chemical class 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000005658 halogenation reaction Methods 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- XNMWTPWQILTFRI-UHFFFAOYSA-N 2-chloro-N-[[4-[2-(N-cyano-S-methylsulfinimidoyl)phenyl]phenyl]methyl]-N-[(4-methylphenyl)methyl]benzamide Chemical class Cc1ccc(CN(Cc2ccc(cc2)-c2ccccc2\S(C)=N\C#N)C(=O)c2ccccc2Cl)cc1 XNMWTPWQILTFRI-UHFFFAOYSA-N 0.000 description 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical compound C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- AKEPZOFDLMZKDT-UHFFFAOYSA-N [SH2]=NC#N Chemical class [SH2]=NC#N AKEPZOFDLMZKDT-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- NSHIYIMHYBAIEY-UHFFFAOYSA-N ethyl hypochlorite Chemical compound CCOCl NSHIYIMHYBAIEY-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- IVMHDOBGNQOUHO-UHFFFAOYSA-N oxathiane Chemical compound C1CCSOC1 IVMHDOBGNQOUHO-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- ORQYPOUSZINNCB-UHFFFAOYSA-N potassium;hypobromite Chemical compound [K+].Br[O-] ORQYPOUSZINNCB-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- HNNKDQSGUCSXBD-UHFFFAOYSA-N propan-2-yl hypobromite Chemical compound C(C)(C)OBr HNNKDQSGUCSXBD-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 150000003463 sulfur Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、硫黄原子上に光学活性を有する新規な光学活
性N一ハロスルフィルィミン類、の製造方法に係わる。
更に詳記すると硫黄原子上に光学活性を有するスルフィ
ルィミン類〔1〕のハロゲン化により、相当する光学活
性N−ハロスルフィルィミン類を製造する方法に関する
。一般に、光学活性体が安定か不安定かは予測し難く、
光学的に不安定な活性体は室温に放置するでけでもラセ
ミ化するのであるが、このようなラセミ化は、熱、光、
溶媒に溶かすなど、の物理的原因あるいはアルカリ、酸
などの化学的原因により生ずる。
このため、炭素化合物を除いては、ある光学活性体に関
する化学反応が、立体保持で進行するのか、反転を伴な
いあるいはラセミ化を伴なつて進行するのかを予測する
ことは、一般には著しく困難なことである。
特に有機硫黄化合物の場合、反応に、硫黄の空の桝軌道
の関与も考えられ、炭素の場合以上に予測が難しい。一
方、S→N骨格を有する有機化合物は、その特異な化学
構造に起因して、医薬品、界面活性剤、樹脂の添加剤、
溶剤、塗料、農薬、有機合成中間体等として有用な化合
物であるが、その光学活性体に関しては、禾だ充分な知
見は得られていない。
しかしながら、S→N骨格を有する光学活性化合物は上
述の種々の用途に加えて、それが光学活性体であるとい
う特定の性質に起因して、光学分割試剤、選択的若しく
は独占的に薬効を有する医薬品、不整合成用試剤、各種
酵素のモデル化合物等としての用途を加算的あるいは相
乗的に有し、そのため、これらの有用な光学活性化合物
を提供する製造方法が要望されている。
即ち、N−ハロスルフイルイミン類DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing novel optically active N-halosulfimines having optical activity on the sulfur atom. More specifically, the present invention relates to a method for producing corresponding optically active N-halosulfimines by halogenating sulfilimines [1] having optical activity on the sulfur atom. Generally, it is difficult to predict whether an optically active substance is stable or unstable;
Optically unstable active substances will racemize even if left at room temperature, but such racemization can be caused by heat, light,
It is caused by physical causes such as dissolving in a solvent, or chemical causes such as alkalis and acids. For this reason, with the exception of carbon compounds, it is generally extremely difficult to predict whether a chemical reaction involving a certain optically active substance will proceed with steric retention, inversion, or racemization. That's true. Particularly in the case of organic sulfur compounds, empty square orbitals of sulfur may be involved in the reaction, which is even more difficult to predict than in the case of carbon. On the other hand, organic compounds with an S→N skeleton are used as additives for pharmaceuticals, surfactants, and resins due to their unique chemical structures.
Although it is a useful compound as a solvent, paint, agricultural chemical, intermediate for organic synthesis, etc., sufficient knowledge has not yet been obtained regarding its optically active form. However, in addition to the various uses mentioned above, an optically active compound with an S→N skeleton can also be used as an optical resolution agent, selectively or exclusively having medicinal properties, due to its specific property of being an optically active entity. They have additive or synergistic uses as pharmaceuticals, reagents for asymmetric synthesis, model compounds for various enzymes, etc., and therefore there is a need for a production method that provides these useful optically active compounds. That is, N-halosulfuimines
〔0〕は、空気中、
室温に置くと、相当するスルホニウム塩を与え、室温で
スルフィド、ホスフイン、アミン等と反応して相当する
スルホニウム塩を与え、室温でアシル化して相当するN
−アシル体を与え、4500でアルカリ処理して相当す
るスルホキシイミン類を与え、室温でシアン化アルカリ
処理してN−シァノスルフィルィミン類を与え、アルキ
ル化剤、アリール化剤と反応し、N−アルキルスルフィ
ルィミン、N−アリールスルフィルィミン等を与えるな
ど、緩和な条件で種々の有用な有機スルフィルィミン系
化合物を与える、反応性に富む化合物であるが、その光
学活性体である〔D〕を製造した例は、今日まで絶無で
ある。
本発明者等は、これらの事実に鑑み鋭意研究し、光学活
性スルフィルィミン類〔1〕とハ。
ゲン化剤との反応がラセミ化を伴なわないで進行するこ
とを見出だし、本発明を完成した。 ※即ち、本発
明は、式:
〔式中、R1、R2は任意に、フェニル基、又は低級ア
ルコキシ置換フェニル基を示す。
〕で表わされる硫黄原子上に光学活性を有するスルフイ
ルイミン類と、Nーハロサクシンイミドとを、非プロト
ン溶媒中、室温乃至冷却下、反応させることを特徴とす
る、式:
〔式中、R1、R2は前記と同じ。
Xはハロゲン原子を示す。〕で表わされる硫黄原子上に
光学活性を有するN−ハロスルフィルィミン類の製造法
である。
光学活性スルフィルィミン類〔1〕とハロゲン化剤との
反応の機構は定かではないが、次式mにおいて示される
如く、例えば、〔1〕aのハロゲン化反応により得られ
る[0] is in the air,
When kept at room temperature, it gives the corresponding sulfonium salt; at room temperature it reacts with sulfide, phosphine, amine, etc. to give the corresponding sulfonium salt, and at room temperature it acylates to give the corresponding N
- acyl form, treated with alkali at 4500 to give corresponding sulfoximines, treated with alkali cyanide at room temperature to give N-cyanosulfilimines, and reacted with an alkylating agent and an arylating agent, It is a highly reactive compound that provides various useful organic sulfilimine compounds under mild conditions, such as N-alkyl sulfilimine, N-arylsulfilimine, etc., and its optically active form. To date, there are no examples of manufacturing [D]. In view of these facts, the present inventors conducted extensive research and discovered optically active sulfilimines [1] and c. The present invention was completed based on the discovery that the reaction with a genifying agent proceeds without racemization. *That is, the present invention is based on the formula: [In the formula, R1 and R2 optionally represent a phenyl group or a lower alkoxy-substituted phenyl group. ] A sulfuilimine having optical activity on a sulfur atom represented by the formula: [wherein R1, R2 is the same as above. X represents a halogen atom. ] This is a method for producing N-halosulfimines having optical activity on the sulfur atom. Although the mechanism of the reaction between the optically active sulfilimines [1] and the halogenating agent is not clear, as shown in the following formula m, for example, it can be obtained by the halogenation reaction of [1]a.
〔0〕aを脱ハロゲン化還元反応すると、最初の〔1
〕aと同程度の旋光度を有する〔1〕aが得られること
などから、本発明に係わるハロゲン化反応はラセミ化を
伴なわないで光学収率良く進行することが解る。
本発明は、例えば次のようにして、実施することができ
る。
原料の光学活性スルフィルィミン類は、例えば、光学活
性N−スルホニルスルフィルィミン類を酸処理して得ら
れる光学活性スルフィルィミン類のスルホン酸塩、をア
ルカリで処理する方法等によって得ることができる。こ
のようにして得られた光学活性体スルフィルィミン類〔
1〕を、要すれば溶媒の存在下に、ハロゲン化剤と混合
し、反応させる。反応後は、常法に従い分離し、要すれ
ば精製する等は任意である。通常、原料として用いられ
る光学活性スルフィルィミン類又は生成する光学活性N
−ハロスルフィルィミン類の光学的安定性等を考慮して
、反応温度等の反応条件は適切に選択され、光学活性ス
ルフィルィミン類とハロゲン化剤との反応モル比は通常
1:1程度が選択される。反応は通常室温付近で行うが
、要すれば冷却してもかまわない。又、ラセミ化を防ぐ
ため、反応系全体を60oo以下で取り扱うのが好まし
い。本発明に係わるハロゲン化剤はハロゲン系酸化剤で
あることが好ましく、通常のハロゲン系酸化剤が支障な
く用いられるが、その若千を例示すると、例えば、塩素
、臭素、沃素などのハロゲン、次亜塩素酸ナトリウム、
次亜臭素酸カリ、次亜塩素酸カルシウムなどの次亜ハロ
ゲン酸塩、次亜塩素酸エチル、次亜臭素酸ィソプロピル
、次亜塩素酸にrt−ブチル等の次亜ハロゲン酸アルキ
ル、N−クロロサクシンイミド、N−ブロモサクシンイ
ミド等のN−ハロサクシンィミド、クロラミンTなどが
挙げられるが、これらのハロゲン系酸化剤を1種又は数
種混合して用いてもよい。
本発明に係わるアルキル基の例としては、例えば、メチ
ル基、エチル基、プロピル基、ブチル基、にrtーブチ
ル基、ヘキシル基、2−エチルヘキシル基、ドデシル基
等の飽和アルキル基、シクロプロピル基、シクロヘキシ
ル基等の飽和シクロァルキル基、ビニル基、1ープロベ
ニル基、4ーヘキセニル基、9−ペンタデセニル等の不
飽和アルキル基、シクロヘキセニル基等の不飽和シクロ
アルキル等が挙げられ、本発明に係わるアリール基の例
としてはフェニル基、ナフチル基等が挙げられる。
又、RIとR2が環をなす含硫黄環状化合物の骨格とし
ては、チオラン、チアン、オキサチアン、1・2−ジヒ
ドロチオナフテン、ベンゾチアン、チアビシクロヘプタ
ン、フエノキサチン、フヱノチアジン、チオキサンセン
、ペニシリン、セフアロスポリン等が挙げられらる。
本発明の置換含硫黄環状化合物、置換ァルキル基及び置
換アリール基に係わる置換基の例としては、炭化水素基
の外には、例えば、ハロゲン、アルコキシ基、アリーロ
キシ基、アルキルチオ基、アリールチオ基、ニトロ基、
シア/基、アシル基、スルホニル基等が挙げられる。
更に具体的に、本発明によって得られる光学活性N−ハ
ロスルフィルィミンの若千を、例として挙げると、Nー
クロローSーメチルーSーイソプロピルスルフイルイミ
ン、NーブロモーS−メチル−S−フエニルスルフイル
イミン、Nーヨード−S−メチル一S−フエニルスルフ
イルイミン、N−クロロ−SーメチルーSーフエニルス
ルフイルイミン、N−ブロモーSーシクロブロピルーS
ーフエニルスルフイルイミン、Nークロロ−S−エチル
一Sーシクロヘキシルスルフイルイミン、Nープロモ−
S一oーメトキシフエニルーS−エチルスルフイルイミ
ン、NークロローSーエチルーS一pーヱトキシフエニ
ルスルフイルイミン、N−ヨード一S一o−トリル−S
ーフエニルスルフイルイミン、Nークロロ−S一oーメ
チルチオフヱニル−Sーフエニルスルフイルイミン、N
−ブロモーS一oーニトロフエニルーS−フヱニルスル
フイルイミン、N−ヨード−S−o−メトキシフエニル
ーS一p−トリルスルフイルイミン、Nークロロ−S一
o−クロロフエニルスルフイルイミン、NーブロモーS
ーフエニルーS−2・6−ジクロロフエニルスルフイル
イミン、N−クロロ−S−フエニルーS一pーシアノフ
エニルスルフイルイミン、N−ブロモ−S一o−トリル
−S−pートリルスルフイルイミン、S−クロロイミノ
ー2−シアノチオラン、Sーブロモイミノ−2ーメトキ
シチアン、Sークロロイミノー2ーメチル−1・2−ジ
ヒドロチオナフテン、S−ヨードイミノー4・4−ジメ
チルベンゾ〔b〕チアン、S−ブロモイミノ−2−クロ
ロ−7−チアビシクロ〔2・2・1〕へブタン、S−ク
ロロイミノ−4−メチルフエノキサチン、S−クロロイ
ミノ−1一クロロフエノチアジン、S−ヨードイミノ−
4−〆トキシチオキサンセン、S−ブロモイミノーベニ
シリン、S−ブロモイミノセフアロスポリンなどの光学
活性体等が挙げられる。
本発明において、必要であれば用いられる溶媒の例とし
ては、例えば、アセトン、ベンゼン、ク。
ロホルム、ジクロルメタン等が挙げられる。ハ。ゲンの
例としては、例えば塩素、臭素、沃素等が挙げられる。
本発明は、光学分割試剤、不整合成用試剤、選択的若し
くは独占的に薬効を有する医薬品等として有用で、反応
性に富む光学活性N−ハロスルフィルィミン類を提供す
るものであり、斯業に貢献するところ大なるものがある
。
以下に実施例と参考例を述べ、本発明を更に詳細に説明
する。
実施例 1
(一)−(S)一S一oーメトキシフエニル−S−フエ
ニルスルフイルイミン(〔Q〕奪:一194o(C;1
.00、CHC13))0.37夕をアセトン5の‘に
溶かし、氷水俗で冷却し、N−クロロサクシンィミド0
.21夕を速やかに加え溶解後、格を取り除き、室温で
1粉ご間鷹拝し続ける。
反応後、氷水中に反応液を注ぎ、析出する固体(pal
e−yellowcolor)を炉取、乾燥し、ベンゼ
ン/n−へキサンから再結晶して、(一)−(S)一S
−o−メトキシフエニル−S−フエニルーN−クロロス
ルフイルイミン(paleyellowcひs脚)0.
28夕を得る。〔Q〕色5:−790(C;0.29、
CHC13)。m‐p.79〜80℃(decomp.
)。yield:67%。m(KBr);〃SN:斑6
比泳‐1実施例 2
(一)−(S)一S一o−メトキシフエニルーSーフエ
ニルスルフイルイミン(〔Q〕色5−73.9o(C;
1.44、CHC13))を実施例1と同様にして(一
)−(S)一S−o−メトキシフエニル−S−フエニル
−Nークロロスルフイルイミン0.28夕を得る。When [0]a is dehalogenated and reduced, the initial [1
The fact that [1]a having an optical rotation comparable to that of [1]a is obtained indicates that the halogenation reaction according to the present invention proceeds with good optical yield without racemization. The present invention can be implemented, for example, as follows. The raw material optically active sulfilimines can be obtained, for example, by a method of treating with an alkali a sulfonic acid salt of optically active sulfilimines obtained by acid-treating optically active N-sulfonylsulfilimines. Optically active sulfilimines thus obtained [
1] is mixed with a halogenating agent, if necessary in the presence of a solvent, and reacted. After the reaction, it is optional to separate and, if necessary, purify according to a conventional method. Usually, optically active sulfilimines used as raw materials or optically active N produced
- Considering the optical stability of halosulfimines, reaction conditions such as reaction temperature are appropriately selected, and the reaction molar ratio of optically active sulfilimines and halogenating agent is usually about 1:1. selected. The reaction is usually carried out at around room temperature, but may be cooled if necessary. Further, in order to prevent racemization, it is preferable to handle the entire reaction system at a temperature of 60 oo or less. The halogenating agent according to the present invention is preferably a halogen-based oxidizing agent, and ordinary halogen-based oxidizing agents can be used without any problem. sodium chlorite,
Hypohalites such as potassium hypobromite and calcium hypochlorite, ethyl hypochlorite, isopropyl hypobromite, alkyl hypohalites such as rt-butyl hypochlorous acid, N-chloro Examples include succinimide, N-halosuccinimide such as N-bromosuccinimide, chloramine T, and these halogen-based oxidizing agents may be used alone or in combination. Examples of the alkyl group according to the present invention include saturated alkyl groups such as methyl group, ethyl group, propyl group, butyl group, rt-butyl group, hexyl group, 2-ethylhexyl group, dodecyl group, cyclopropyl group, Examples include saturated cycloalkyl groups such as cyclohexyl group, unsaturated alkyl groups such as vinyl group, 1-probenyl group, 4-hexenyl group, and 9-pentadecenyl group, and unsaturated cycloalkyl groups such as cyclohexenyl group. Examples include phenyl group, naphthyl group, etc. Examples of the skeleton of the sulfur-containing cyclic compound in which RI and R2 form a ring include thiolane, thian, oxathian, 1,2-dihydrothionaphthene, benzothian, thiabicycloheptane, phenoxatin, phenothiazine, thioxanthene, penicillin, and cephalosporin. It's coming. Examples of substituents for the substituted sulfur-containing cyclic compounds, substituted alkyl groups, and substituted aryl groups of the present invention include, in addition to hydrocarbon groups, halogens, alkoxy groups, aryloxy groups, alkylthio groups, arylthio groups, nitro basis,
Examples include sia/group, acyl group, and sulfonyl group. More specifically, examples of optically active N-halosulfilimines obtained according to the present invention include N-chloroS-methyl-S-isopropylsulfylimine, N-bromoS-methyl-S-phenylsulfimine, Rufilimine, N-iodo-S-methyl-S-phenylsulfuimine, N-chloro-S-methyl-S-phenylsulfuimine, N-bromo-S-cyclobropyru-S
-Phenylsulfuimine, N-chloro-S-ethyl-S-cyclohexylsulfuimine, N-promo-
S-methoxyphenyl-S-ethylsulfuilimine, N-chloroS-ethyl-S-p-ethoxyphenylsulfuimine, N-iodo-S-tolyl-S
-Phenylsulfyl imine, N-chloro-S-methylthiophenyl-S-phenylsulfyl imine, N
-bromoS-o-nitrophenyl-S-phenylsulfuimine, N-iodo-S-o-methoxyphenyl-S-p-tolylsulfuimine, N-chloro-S-o-chlorophenylsulfuimine , N-bromo S
-Phenyl-S-2,6-dichlorophenylsulfuilimine, N-chloro-S-phenyl-S-p-cyanophenylsulfuimine, N-bromo-S-tolyl-S-p-tolylsulfuimine , S-chloroimino-2-cyanothiolane, S-bromoimino-2-methoxythiane, S-chloroimino-2-methyl-1,2-dihydrothionaphthene, S-iodoimino-4,4-dimethylbenzo[b]thiane, S-bromoimino-2-chloro-7 -thiabicyclo[2.2.1]hebutane, S-chloroimino-4-methylphenoxatin, S-chloroimino-1-chlorophenothiazine, S-iodoimino-
Examples include optically active substances such as 4-toxythioxanthene, S-bromoiminobenicillin, and S-bromoiminocephalosporin. In the present invention, examples of solvents that may be used if necessary include acetone, benzene, and chlorine. Examples include loform and dichloromethane. Ha. Examples of genes include chlorine, bromine, iodine, and the like.
The present invention provides highly reactive optically active N-halosulfimines that are useful as optical resolution reagents, reagents for asymmetric synthesis, pharmaceuticals having selective or exclusive medicinal effects, etc. There is a lot to contribute to this industry. EXAMPLES The present invention will be explained in more detail by referring to Examples and Reference Examples below. Example 1 (1)-(S)-S-methoxyphenyl-S-phenylsulfoylimine ([Q] deprivation: -194o (C; 1
.. 0.00, CHC13)) 0.37% was dissolved in 5 parts of acetone, cooled with ice and water, and N-chlorosuccinimide 0.
.. 21 Add immediately and dissolve, remove the scale and continue to stir for 1 powder at room temperature. After the reaction, pour the reaction solution into ice water to remove the precipitated solid (pal).
(e-yellow color) was collected in a furnace, dried, and recrystallized from benzene/n-hexane to obtain (1)-(S)-S
-o-methoxyphenyl-S-phenyl-N-chlorosulfuimine (paleyellowc) 0.
Get 28 evenings. [Q] Color 5: -790 (C; 0.29,
CHC13). m-p. 79-80°C (decomp.
). Yield: 67%. m (KBr);〃SN: Spot 6
Hypochemistry-1 Example 2 (1)-(S)-S1o-Methoxyphenyl-S-phenylsulfuilimine ([Q] Color 5-73.9o(C;
1.44, CHC13)) was treated in the same manner as in Example 1 to obtain 0.28 g of (1)-(S)-S-o-methoxyphenyl-S-phenyl-N-chlorosulfilimine.
Claims (1)
級アルコキシ置換フエニル基を示す。 〕で表わされる硫黄原子上に光学活性を有するスルフイ
ルイミン類と、N−ハロサクシンイミドとを、非プロト
ン溶媒中、室温乃至冷却下、反応させることを特徴とす
る、 式: ▲数式、化学式、表等があります▼ 〔式中、R^1、R^2は前記と同じ。 Xはハロゲン原子を示す。〕で表わされる硫黄原子上に
光学活性を有するN−ハロスルフイルイミン類の製造法
。[Claims] 1 Formula: ▲ Numerical formula, chemical formula, table, etc.▼ [In the formula, R^1 and R^2 optionally represent a phenyl group or a lower alkoxy-substituted phenyl group. Formula: ▲Mathematical formula, chemical formula, table etc. ▼ [In the formula, R^1 and R^2 are the same as above. X represents a halogen atom. ] A method for producing N-halosulfuimines having optical activity on the sulfur atom.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8431676A JPS6014024B2 (en) | 1976-07-15 | 1976-07-15 | Method for producing optically active N-halosulfilimines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8431676A JPS6014024B2 (en) | 1976-07-15 | 1976-07-15 | Method for producing optically active N-halosulfilimines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS539708A JPS539708A (en) | 1978-01-28 |
| JPS6014024B2 true JPS6014024B2 (en) | 1985-04-11 |
Family
ID=13827094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8431676A Expired JPS6014024B2 (en) | 1976-07-15 | 1976-07-15 | Method for producing optically active N-halosulfilimines |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6014024B2 (en) |
-
1976
- 1976-07-15 JP JP8431676A patent/JPS6014024B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS539708A (en) | 1978-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nishiguchi et al. | Sulfonyl chloride formation from thiol derivatives by N-chlorosuccinimide mediated oxidation | |
| JP3814696B2 (en) | Process for producing aromatic or heteroaromatic sulfonyl halides | |
| JPS6014024B2 (en) | Method for producing optically active N-halosulfilimines | |
| Wojciechowski | Synthesis of Nitrobenzophenones from Nitro-α-Sulfonyldiphenylmethane Derivatives | |
| JPS61257991A (en) | Manufacture of cepham compound | |
| CN115417852B (en) | 5-trifluoromethyl-4H-thiopyran derivatives and process for preparing same | |
| JPH11502218A (en) | Method | |
| PL103103B1 (en) | METHOD OF MAKING 2-CHLOROSULFINYLAZETHIDINONE-4 DERIVATIVES | |
| JPS62132886A (en) | Production of cefodidim | |
| JPS6019289B2 (en) | Method for producing optically active sulfoximines | |
| Kielbasinski et al. | Organosulfur compounds. Part 28. Reduction of sulfonyl halides with iodotrimethylsilane: new observations | |
| CN103087033A (en) | Synthesis method of poly-substituted oxacycloheptatriene-3(2H) ketone compounds | |
| JP4159022B2 (en) | Preparation of diazonaphthoquinonesulfonyl chloride using diphosgene and triphosgene. | |
| CH619451A5 (en) | ||
| CN115385903A (en) | A kind of preparation method of cyano-substituted benzoxazin-4-one derivative | |
| US4187221A (en) | Process for preparing azetidinones | |
| DE2556045A1 (en) | PROCESS FOR THE PREPARATION OF 3-METHYLENCEPHAMSULFOXIDES | |
| JPS5944356A (en) | Preparation of azetidinone derivative | |
| JPS60132951A (en) | Improved manufacture of sulfonamide derivative | |
| JPH01102083A (en) | Production f zinc salt of salicylic acid derivative | |
| JPS6019288B2 (en) | Method for producing optically active N-substituted diarylsulfuimine | |
| JPH0426678A (en) | Method for producing imidazole-4-chloro-5-carbaldehyde derivative | |
| Whitmore et al. | ORGANIC MERCURY COMPOUNDS PREPARED FROM ORTHO-CHLOROMERCURI-PARA-NITROBENZOYL CHLORIDE1 | |
| JPS61126066A (en) | Novel method of polysulfide production | |
| JPH08245573A (en) | Production of halogenated beta-lactam compound |